Ellis Investment Partners’s Edwards Lifesciences EW Stock Holding History

Ellis Investment Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-852	Closed	-$70K	–	367
2022 Q3	$70K	Buy	852 +144	+20%	+$13.9K	0.02%	341
2022 Q2	$67K	Hold	708	–	–	0.02%	364
2022 Q1	$83K	Hold	708	–	–	0.02%	348
2021 Q4	$91K	Hold	708	–	–	0.02%	336
2021 Q3	$80K	Hold	708	–	–	0.02%	343
2021 Q2	$73K	Hold	708	–	–	0.02%	352
2021 Q1	$59K	Sell	708 -105	-13%	-$8.88K	0.02%	366
2020 Q4	$74K	Hold	813	–	–	0.02%	327
2020 Q3	$64K	Hold	813	–	–	0.02%	324
2020 Q2	$56K	Hold	813	–	–	0.02%	339
2020 Q1	$46K	Hold	813	–	–	0.02%	311
2019 Q4	$63K	Hold	813	–	–	0.02%	309
2019 Q3	$58K	Hold	813	–	–	0.02%	316
2019 Q2	$50K	Buy	+813	New	+$49.2K	0.02%	324

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ellis Investment Partners's EW Position: Q4 2022 in Review

Ellis Investment Partners sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 852 shares — an estimated $70K sold.

Ellis Investment Partners first reported a position in EW in Q2 2019 and held it in 14 quarters. The position peaked at $91K in Q4 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

Ellis Investment Partners reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
Ellis Investment Partners sold 852 Edwards Lifesciences shares in Q4 2022, an estimated $70K.
Ellis Investment Partners first reported a position in Edwards Lifesciences in Q2 2019 and held it in 14 quarters.
Ellis Investment Partners's Edwards Lifesciences position peaked at $91K in Q4 2021.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.